Literature DB >> 7910611

Differential protein import deficiencies in human peroxisome assembly disorders.

A Motley1, E Hettema, B Distel, H Tabak.   

Abstract

Two peroxisome targeting signals (PTSs) for matrix proteins have been well defined to date. PTS1 comprises a COOH-terminal tripeptide, SKL, and has been found in several matrix proteins, whereas PTS2 has been found only in peroxisomal thiolase and is contained within an NH2-terminal cleavable presequence. We have investigated the functional integrity of the import routes for PTS1 and PTS2 in fibroblasts from patients suffering from peroxisome assembly disorders. Three of the five complementation groups tested showed a general loss of PTS1 and PTS2 import. Two complementation groups showed a differential loss of peroxisomal protein import: group I cells were able to import a PTS1- but not a PTS2- containing reporter protein into their peroxisomes, and group IV cells were able to import the PTS2 but not the PTS1 reporter into aberrant, peroxisomal ghostlike structures. The observation that the PTS2 import pathway is intact only in group IV cells is supported by the protection of endogenous thiolase from protease degradation in group IV cells and its sensitivity in the remaining complementation groups, including the partialized disorder of group I. The functionality of the PTS2 import pathway and colocalization of endogenous thiolase with the peroxisomal membranes in group IV cells was substantiated further using immunofluorescence, subcellular fractionation, and immunoelectron microscopy. The phenotypes of group I and IV cells provide the first evidence for differential import deficiencies in higher eukaryotes. These phenotypes are analogous to those found in Saccharomyces cerevisiae peroxisome assembly mutants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910611      PMCID: PMC2120069          DOI: 10.1083/jcb.125.4.755

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  50 in total

1.  In vitro synthesis of peroxisomal membrane polypeptides.

Authors:  A Köster; M Heisig; P C Heinrich; W W Just
Journal:  Biochem Biophys Res Commun       Date:  1986-06-13       Impact factor: 3.575

2.  Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome.

Authors:  S Goldfischer; C L Moore; A B Johnson; A J Spiro; M P Valsamis; H K Wisniewski; R H Ritch; W T Norton; I Rapin; L M Gartner
Journal:  Science       Date:  1973-10-05       Impact factor: 47.728

Review 3.  Peroxisomal disorders: a newly recognised group of genetic diseases.

Authors:  R B Schutgens; H S Heymans; R J Wanders; H van den Bosch; J M Tager
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

4.  Rhizomelic chondrodysplasia punctata: another peroxisomal disorder.

Authors:  H S Heymans; J W Oorthuys; G Nelck; R J Wanders; R B Schutgens
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

5.  Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients.

Authors:  A A Roscher; S Hoefler; G Hoefler; E Paschke; F Paltauf; A Moser; H Moser
Journal:  Pediatr Res       Date:  1989-07       Impact factor: 3.756

6.  Peroxisomal beta-oxidation enzyme proteins in the Zellweger syndrome.

Authors:  J M Tager; W A Van der Beek; R J Wanders; T Hashimoto; H S Heymans; H Van den Bosch; R B Schutgens; A W Schram
Journal:  Biochem Biophys Res Commun       Date:  1985-02-15       Impact factor: 3.575

7.  Firefly luciferase is targeted to peroxisomes in mammalian cells.

Authors:  G A Keller; S Gould; M Deluca; S Subramani
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Activity of peroxisomal enzymes and intracellular distribution of catalase in Zellweger syndrome.

Authors:  R J Wanders; M Kos; B Roest; A J Meijer; G Schrakamp; H S Heymans; W H Tegelaers; H van den Bosch; R B Schutgens; J M Tager
Journal:  Biochem Biophys Res Commun       Date:  1984-09-28       Impact factor: 3.575

Review 9.  Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes.

Authors:  R I Kelley; N S Datta; W B Dobyns; A K Hajra; A B Moser; M J Noetzel; E H Zackai; H W Moser
Journal:  Am J Med Genet       Date:  1986-04

10.  Deficient activities and proteins of peroxisomal beta-oxidation enzymes in infants with Zellweger syndrome.

Authors:  Y Suzuki; T Orii; M Mori; M Tatibana; T Hashimoto
Journal:  Clin Chim Acta       Date:  1986-04-30       Impact factor: 3.786

View more
  38 in total

1.  Disorders of peroxisome biogenesis: complementation analysis shows genetic heterogeneity with strong overrepresentation of one group (PEX1 deficiency).

Authors:  R J Wanders; P A Mooijer; C Dekker; Y Suzuki; N Shimozawa
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

Review 2.  Rhizomelic chondrodysplasia punctata, a peroxisomal biogenesis disorder caused by defects in Pex7p, a peroxisomal protein import receptor: a minireview.

Authors:  P E Purdue; M Skoneczny; X Yang; J W Zhang; P B Lazarow
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Involvement of the endoplasmic reticulum in peroxisome formation.

Authors:  Hans J Geuze; Jean Luc Murk; An K Stroobants; Janice M Griffith; Monique J Kleijmeer; Abraham J Koster; Arie J Verkleij; Ben Distel; Henk F Tabak
Journal:  Mol Biol Cell       Date:  2003-04-04       Impact factor: 4.138

4.  Saccharomyces cerevisiae pex3p and pex19p are required for proper localization and stability of peroxisomal membrane proteins.

Authors:  E H Hettema; W Girzalsky; M van Den Berg; R Erdmann; B Distel
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

Review 5.  The surprising complexity of peroxisome biogenesis.

Authors:  L J Olsen
Journal:  Plant Mol Biol       Date:  1998-09       Impact factor: 4.076

6.  Cholesterol biosynthesis in Zellweger syndrome: normal activity of mevalonate kinase, mevalonate-5'-pyrophosphate decarboxylase and IPP-isomerase in patients' fibroblasts but deficient mevalonate kinase activity in liver.

Authors:  R J Wanders; G J Romeijn
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

7.  Phytanoyl-CoA hydroxylase is not only deficient in classical Refsum disease but also in rhizomelic chondrodysplasia punctata.

Authors:  G A Jansen; S J Mihalik; P A Watkins; H W Moser; C Jakobs; H S Heijmans; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

8.  Localization and targeting of isocitrate lyases in Saccharomyces cerevisiae.

Authors:  K M Taylor; C P Kaplan; X Gao; A Baker
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

9.  Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.

Authors:  Michael J Lumb; Graeme M Birdsey; Christopher J Danpure
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  The Pichia pastoris PER6 gene product is a peroxisomal integral membrane protein essential for peroxisome biogenesis and has sequence similarity to the Zellweger syndrome protein PAF-1.

Authors:  H R Waterham; Y de Vries; K A Russel; W Xie; M Veenhuis; J M Cregg
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.